The Engineered Bacteria targets the SCORPION VENOM PEPTIDE AGAP for target breast cancer therapy

The Engineered Bacteria targets the SCORPION VENOM PEPTIDE AGAP for target breast cancer therapy

Incidental increase and rate mortality in malignant boils highlight their great impact on human health. Bacteria therapy emerges as a promising avenue of oncological research. Our lab has lonely an analgesic-anti-tumor peptide from the poison of Buthus Marketsii Karsch (BMK Agap), a high scorpion venom peptide, showing extraordinary anti-tumor activity. However the limited bioavailability of…

Read More